Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias

Nature Communications

Volumn 6, Issue , 2015, Pages

  Gardner, R T ^a   Wang, L ^b   Lang, B T ^c   Cregg, J M ^c   Dunbar, C L ^a   Woodward, W R ^d   Silver, J ^c   Ripplinger, C M ^b   Habecker, B A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SIGMA; PROTEOCHONDROITIN SULFATE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR; CALCIUM; PEPTIDE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

AMINO ACID; CALCIUM; CARDIOVASCULAR DISEASE; DISEASE TREATMENT; ENZYME ACTIVITY; HEALTH RISK; OPTICAL METHOD; PEPTIDE; PROTEIN;

ACTION POTENTIAL DURATION; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEART ARRHYTHMIA; HEART DENERVATION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART INFARCTION SIZE; HEART INNERVATION; HEART RATE; MOUSE; NERVE FIBER REGENERATION; NONHUMAN; PROTEIN TARGETING; SCAR; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; ANTAGONISTS AND INHIBITORS; ARRHYTHMIAS, CARDIAC; BAGG ALBINO MOUSE; ELECTROCARDIOGRAPHY; FEMALE; GENETICS; MALE; METABOLISM; MYOCARDIAL INFARCTION; TRANSGENIC MOUSE;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; ELECTROCARDIOGRAPHY; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; PEPTIDES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RECEPTORS, ADRENERGIC, BETA; SYMPATHETIC NERVOUS SYSTEM;

EID: 84923084249     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7235     Document Type: Article

References (57)

1. Solomon, S. D. et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N. Engl. J. Med. 352, 2581-2588 (2005).
2. Jalife, J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu. Rev. Physiol. 62, 25-50 (2000).
3. Nademanee, K., Taylor, R., Bailey, W. E., Rieders, D. E. & Kosar, E. M. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102, 742-747 (2000).
4. Basu, S. et al. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. Circulation 96, 183-191 (1997).
5. Billman, G. E., Castillo, L. C., Hensley, J., Hohl, C. M. & Altschuld, R. A. Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96, 1914-1922 (1997).
6. Exner, D. V. et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J. Am. Coll. Cardiol. 34, 325-333 (1999).
7. Schwartz, P. J. et al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J. Cardiovasc. Electrophysiol. 3, 2-16 (1992).
8. Thomas, D., Kiehn, J., Katus, H. A. & Karle, C. A. Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, I(Kr), and the underlying hERG ion channel. Basic Res. Cardiol. 99, 279-287 (2004).
9. Cutler, M. J., Jeyaraj, D. & Rosenbaum, D. S. Cardiac electrical remodeling in health and disease. Trends Pharmacol. Sci. 32, 174-180 (2011).
10. Bers, D. M. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 70, 23-49 (2008).
11. Ieda, M. et al. Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat. Med. 13, 604-612 (2007).
12. Lorentz, C. U. et al. Heterogeneous ventricular sympathetic innervation, altered {beta} adrenergic receptor expression, and rhythm instability in mice lacking p75 neurotrophin receptor. Am. J. Physiol. Heart Circ. Physiol. 298, H1652-H1660 (2010).
13. Li, W., Knowlton, D., Van Winkle, D. M. & Habecker, B. A. Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am. J. Physiol. Heart Circ. Physiol. 286, H2229-H2236 (2004).
14. Dae, M. W., O'Connell, J. W., Botvinick, E. H. & Chin, M. C. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc. Res. 30, 270-280 (1995).
15. Simula, S. et al. Cardiac adrenergic innervation within the first 3 months after acute myocardial infarction. Clin. Physiol. 20, 366-373 (2000).
16. Stanton, M. S. et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J. Am. Coll. Cardiol. 14, 1519-1526 (1989).
17. Barber, M. J., Mueller, T. M., Henry, D. P., Felten, S. Y. & Zipes, D. P. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67, 787-796 (1983).
18. Boogers, M. J. et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J. Am. Coll. Cardiol. 55, 2769-2777 (2010).
19. Nishisato, K. et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J. Nucl. Med. 51, 1241-1249 (2010).
20. Fallavollita, J. A. et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J. Am. Coll. Cardiol. 63, 141-149 (2014).
21. Vaseghi, M., Lux, R. L., Mahajan, A. & Shivkumar, K. Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 302, H1838-H1846 (2012).
22. Rubart, M. & Zipes, D. P. Mechanisms of sudden cardiac death. J. Clin. Invest. 115, 2305-2315 (2005).
23. Gardner, R. T. & Habecker, B. A. Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury. J. Neurosci. 33, 7175-7183 (2013).
24. Lorentz, C. U. et al. Sympathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor. Exp. Neurol. 249, 111-119 (2013).
25. Bai, R. et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circulation 4, 478-485 (2011).
26. Lang, B. et al. Systemic modulation of the proteoglycan receptor PTPs promotes functional recovery after spinal cord injury. Nature; doi: 10.1038/nature13974 (2014).
27. Parrish, D. C. et al. Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves. Exp. Physiol. 95, 304-314 (2009).
28. Kimura, K. et al. Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ. Res. 100, 1755-1764 (2007).
29. Shi, X. & Habecker, B. A. gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2. J. Neurochem. 120, 239-247 (2012).
30. Dobaczewski, M. et al. Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res. 324, 475-488 (2006).
31. Banville, I. & Gray, R. A. Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J. Cardiovasc. Electrophysiol. 13, 1141-1149 (2002).
32. Knollmann, B. C., Schober, T., Petersen, A. O., Sirenko, S. G. & Franz, M. R. Action potential characterization in intact mouse heart: steady-state cycle length dependence and electrical restitution. Am. J. Physiol. Heart Circ. Physiol. 292, H614-H621 (2007).
33. Lue, W. M. & Boyden, P. A. Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current. Circulation 85, 1175-1188 (1992).
34. Bru-Mercier, G. et al. Expression of heart K+ channels in adrenalectomized and catecholamine-depleted reserpine-treated rats. J. Mol. Cell Cardiol. 35, 153-163 (2003).
35. Muller, J. E. et al. Circadian variation in the frequency of sudden cardiac death. Circulation 75, 131-138 (1987).
36. Scheer, F. A. et al. Impact of the human circadian system, exercise, and their interaction on cardiovascular function. Proc. Natl Acad. Sci. USA 107, 20541-20546 (2010).
37. Wilson, L. D., Wan, X. & Rosenbaum, D. S. Cellular alternans: a mechanism linking calcium cycling proteins to cardiac arrhythmogenesis. Ann. N. Y. Acad. Sci. 1080, 216-234 216-234 (2006).
38. Myles, R. C., Wang, L., Kang, C., Bers, D. M. & Ripplinger, C. M. Local beta-adrenergic stimulation overcomes source-sink mismatch to generate focal arrhythmia. Circ. Res. 110, 1454-1464 (2012).
39. Erickson, J. R. et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 502, 372-376 (2013).
40. Vaseghi, M. et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long term follow up. Heart Rhythm 11, 6 (2014).
41. Lopez-Sendon, J. et al. Expert consensus document on beta-adrenergic receptor blockers. Eur. Heart J. 25, 1341-1362 (2004).
42. Cao, J. M. et al. Nerve sprouting and sudden cardiac death. Circ. Res. 86, 816-821 (2000).
43. Cao, J. M. et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101, 1960-1969 (2000).
44. Zhou, S. et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ. Res. 95, 76-83 (2004).
45. Hasan, W. et al. Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res. 1124, 142-154 (2006).
46. Oh, Y. S. et al. Spatial distribution of nerve sprouting after myocardial infarction in mice. Heart Rhythm 3, 728-736 (2006).
47. Moss, A. J. et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877-883 (2002).
48. Goldenberg, I. et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 122, 1265-1271 (2010).
49. Nerbonne, J. M. Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities. Curr. Opin. Pharmacol. 15, 107-114 (2014).
50. Jouven, X. et al. Heart-rate profile during exercise as a predictor of sudden death. N. Engl. J. Med. 352, 1951-1958 (2005).
51. Elchebly, M. et al. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat. Genet. 21, 330-333 (1999).
52. Faggioni, M. et al. Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. Circ. Res. 112, 689-697 (2013).
53. Nebel, M. et al. Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling and arrhythmias in the heart evoked by b-adrenergic stimulation. J. Biol. Chem. 288, 16017-16030 (2013).
54. Bayly, P. V. et al. Estimation of conduction velocity vector fields from epicardial mapping data. IEEE Trans. Biomed. Eng. 45, 563-571 (1998).
55. Verrier, R. L. et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility-consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J. Am. Coll. Cardiol. 58, 1309-1324 (2011).
56. Myles, R. C., Burton, F. L., Cobbe, S. M. & Smith, G. L. Alternans of action potential duration and amplitude in rabbits with left ventricular dysfunction following myocardial infarction. J. Mol. Cell Cardiol. 50, 510-521 (2011).
57. Wang, L. et al. Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation. Circ. Res. 114, 1410-1421 (2014).